Grace Therapeutics (GRCE) Stock: Buy, Sell, or Hold?
GRCE - Grace Therapeutics, Inc. Common Stock
$1.93
0.01 (0.78%)
▲
5d:
+2.12%
30d:
-10.65%
90d:
-16.09%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 12, 2026
18d
Get Alerted When GRCE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: GRCE shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: GRCE shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: GRCE is currently trading at $1.93, which is considered oversold relative to its 30-day fair value range of $1.96 to $2.14.
Technical Outlook: Technically, GRCE is in a strong downtrend. Immediate support is located at $1.82, while resistance sits at $2.07.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.95 (+208.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GRCE is in a strong downtrend. Immediate support is located at $1.82, while resistance sits at $2.07.
Market Sentiment: The stock scores a mixed 57/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $5.95 (+208.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.96 -
$2.14
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (57/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 208.5% below Wall St target ($5.95)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.96 -
$2.14
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.82
Resistance Level
$2.07
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.03
Wall Street Target
$5.95
(+208.5%)
Share & Embed Analysis
Last updated: October 24, 2026 3:13 PM ET
Data refreshes hourly during market hours. Next update: 4:13 PM
Data refreshes hourly during market hours. Next update: 4:13 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRCE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$571 | 58 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$369 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
27 analysts |
$436 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 51 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
18 analysts |
$144 | 75 BUY |